Y-Biologics Inc. Company Profile - South Korea | Financials & Key Executives

The Company is a Korea-based company principally engaged in the new drug development business. The Company is principally engaged in the research and development of new cancer antibody drugs for small cell lung cancer, liver cancer, solid cancer as well as others. The Company was established on December 31, 2007. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 5, 2023.

Headquarters
B715, 17, Techno 4-Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Y-Biologics Inc. report to view the information.

Website: http://ybiologics.com

Basic Information

Outstanding Shares:

Purchase the Y-Biologics Inc. report to view the information.

Incorporation Date:

2007

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Company Performance

Financial values in the chart are available after Y-Biologics Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Total operating revenue

-14.17%▼

Y-Biologics Inc. (South Korea)